Author, publication year, (Ref.)

Participants

Statin

Mean LDL-C reduction (%)

Method

Main results

 

At baseline

At follow-up

Type

Dose (mg)

Duration

 

 

 

 

Wiegman, 2004 (20)

FH with statins (n = 106, 13 ± 3.0 yrs), FH with placebo (n = 108, 13 ± 2.9 yrs)

FH with statins (n = 104, 15 ± 3.0 yrs), FH with placebo (n = 107, 15 ± 2.9 yrs)

pravastatin

20-40

2 yrs

24.1

carotid IMT

Regression of IMT in adolescents after 2 years of pravastatin compared to those who got placebo.

 

Hedman, 2005 (32)

FH (n = 30, 10.1 ± 3.4 yrs)

FH (n = 30)

pravastatin

Oct-60

1 – 2 yrs

33.1

carotid IMT

Non-significant increase in the IMT after 1 and 2 years of pravastatin.

 

van der Graaf, 2006 (23)

FH (n = 84, 12.6 ± 2.1 yrs)

FH (n = 84, 14.6 ± 2.1 yrs)

fluvastatin

80

2 yrs

33.9

carotid IMT

No differences in IMT after 2 years of fluvastatin therapy.

 

Rodenburg, 2007 (30)

FH (n = 186, 13.7 ± 3.1 yrs)

FH (n = 186, 18.2 ± 2.6 yrs)

pravastatin

20-40

2 yrs

29.2

carotid IMT

Regression of IMT in adolescents after early initiation of pravastatin.

 

Kusters, 2014 (14)

FH (n = 194, 12.9 ± 0.5 yrs), unaffected sibling (n = 83, 13.0 ± 0.7 yrs)

FH (n = 19.4, 24.0 ± 0.5 yrs), unaffected siblings (n – 83, 23.8 ± 0.7 yrs)

pravastatin

20-40

10 yrs

27.1

carotid IMT

Increased IMT in FH compared to unaffected siblings at baseline. Same progression of IMT after 10 years of Pravastatin, but still significantly greater IMT.

 
 

Braamskamp, 2017 (31)

FH (n = 198, 12.1 ± 3.3 yrs), unaffected siblings (n = 65, 12.0 ± 3.5 yrs)

FH (n = 197), unaffected siblings (n = 65)

rosuvastatin

Oct-20

2 yrs

41

carotid IMT

Increased IMT in FH compared to unaffected siblings at baseline. Less progression of IMT in children with FH after 2 yrs Rosuvastatin.

 
 

Luirink, 2019 (29)

FH (n = 214, 13.0 ± 2.9 yrs), unaffected siblings (n = 95, 12.9 ± 2.9)

FH (n = 184, 31.7 ± 3.2 yrs), unaffected siblings (n = 77, 31.6 ± 3.0 yrs)

pravastatin

20-40

20 yrs

32

carotid IMT

Increased IMT in FH compared to unaffected siblings at baseline. Slowed progression of IMT after 20 years of Pravastatin.

 

simvastatin

20-80

 

atorvastatin

Oct-80

 

rosuvastatin

May-40

 

Hennig, 2020 (28)

FH (n = 57, 9.57 ± 3.26 yrs)

FH with diet only (n = 12), FH with statin (n = 20)

rosuvastatin

May-40

1 yr

34.4

Carotid IMT

Insignificant decrease in the IMT after 1 year of statin treatment.